PRECISION BIOSCIENCES INC Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Precision Biosciences Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Precision Biosciences Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.93M, a 24.4% decline year-over-year.
  • Precision Biosciences Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $11.9M, a 32.5% decline year-over-year.
  • Precision Biosciences Inc annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 26.9% decline from 2022.
  • Precision Biosciences Inc annual Share-based Payment Arrangement, Expense for 2022 was $19.2M, a 16.2% increase from 2021.
  • Precision Biosciences Inc annual Share-based Payment Arrangement, Expense for 2021 was $16.5M, a 19.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14M -$5.16M -26.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $19.2M +$2.68M +16.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $16.5M +$2.73M +19.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $13.8M +$4.85M +54.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $8.94M +$6.49M +264% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 $2.45M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.